Overview

• Up to 12.24 million shares were allocated at €66 each, valuing the prosthetics maker at about €4.22 billion after reports of multiple oversubscription.
• Trading is scheduled to begin on 9 October in Frankfurt in the Prime Standard segment.
• Private investors received roughly 4.7% of the placement, with full allocation for orders up to 20 shares and about 12% for the excess portion of larger orders up to 500 shares.
• The offering could raise up to about €808 million, including roughly €100 million in primary proceeds for Ottobock, while the remainder comes from a secondary sale; free float would be around 19% if all shares are sold.
• The Näder family is set to remain above 80% ownership, with reported anchor commitments from Klaus‑Michael Kühne (up to €125 million) and Smallcap World Fund (~€115 million), and BNP Paribas, Deutsche Bank and Goldman Sachs leading the syndicate.